Business Context and Reporting Period
Company: Zimmer Holdings, Inc. (Note: Filing lists "Zimmer Holdings, Inc." while metadata references "Zimmer Biomet Holdings, Inc.")
Filing Type: Form 8-K (Current Report)
Date of Report: January 31, 2013
Reporting Period: Results of operations for the quarter and full year ended December 31, 2012.
Key Financial Metrics
This Form 8-K serves as a notification of the earnings release and does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The filing states that detailed financial results are contained in the attached Exhibit 99.1 (Press Release), which is incorporated by reference.
The filing highlights the use of two types of non-GAAP financial measures in the referenced press release:
- Constant Currency Sales: Sales translated at predetermined exchange rates to exclude foreign currency effects.
- Adjusted Operating Performance: Adjusted net earnings and diluted EPS excluding specific one-time items.
Material Changes and Unusual Items
The filing details specific items excluded from non-GAAP adjusted measures to facilitate period-to-period comparisons. These items include:
- Inventory step-up and other inventory charges.
- Special items: Acquisition and integration costs, asset impairment charges related to prior acquisitions, employee termination benefits, consulting fees, litigation matters, and global restructuring costs.
- Specific 2012 Exclusions: A provision for known and anticipated claims relating to the Durom Acetabular Component, a goodwill impairment charge related to the U.S. Spine business, and certain tax adjustments.
- Specific 2011 Exclusions: Inventory step-up, special items, and the Durom Acetabular Component provision.
Guidance, Outlook, and Management Commentary
Guidance: The filing notes that the attached press release includes projected adjusted diluted EPS for the full year 2013. Specific guidance figures are not provided in this text.
Management Commentary: Management utilizes these non-GAAP measures internally to evaluate business performance, identify operating trends masked by special items, and perform trend analysis. Adjusted diluted EPS is also used as a performance metric in incentive compensation programs.
Risks and Contingencies: The filing explicitly references a provision for claims related to the Durom Acetabular Component and a goodwill impairment charge for the U.S. Spine business as material items affecting reported earnings.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific GAAP and non-GAAP revenue, net earnings, and EPS figures for Q4 and Full Year 2012.
- Verify the specific projected adjusted diluted EPS for 2013 mentioned in the press release.
- Examine the reconciliation tables in the press release to understand the exact dollar impact of the Durom Acetabular Component provision and U.S. Spine goodwill impairment.
- Confirm the impact of foreign currency exchange rates on reported sales growth by comparing GAAP sales to constant currency sales.